High-Impact MMR Vaccine for Measles, Mumps, and Rubella - Double Dose Vial for Maximum Protection
ProcurenetShort description
Boost immunity with the High-Impact MMR Vaccine for Measles, Mumps, and Rubella, offered as a two-dose vial of freeze-dried powder. Key Features:
- Dosage: Over 1000 CCID50 of measles, mumps, and rubella virus per dose.
- Formulation: Up to 5000 CCID50 of mumps virus, varying per manufacturer.
- Virus Strains: Pre-approved strains by WHO.
- Composition: Produced in human diploid cells or chicken embryo fibroblasts.
- Shipping & Storage: Preserve at 2u00b0C-8u00b0C, or freeze at -20u00b0C; always protect from sunlight.
- Administration & Immunization: Administer a single 0.5 ml dose via sterile syringe; suitable for individuals aged 9 months and above, with a recommended second dose.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
High-Impact MMR Vaccine for Measles, Mumps and Rubella: 2 Dose Vial
Our High-Impact MMR Vaccine, designed to provide robust protection against measles, mumps, and rubella, is a crucial element in global health defense. With each vial consisting of two doses of freeze-dried vaccine, this product delivers dependable immunity from these highly contagious diseases that continue to pose significant threats to human health worldwide.
Key Product Features
- Comprehensive Protection: Our MMR vaccine offers an all-inclusive defense against measles, mumps, and rubella, rigorously tested for assured efficiency.
- Double Dose Preparation: Each vial includes two doses of freeze-dried powder, sealed to maintain peak efficacy.
- Guaranteed Potency: Every dose is loaded with a minimum of 1000 CCID50 of the respective viruses, promising strong and lasting immunity.
Vaccine Administration and Immunization Schedule
A single dose of 0.5 ml should be injected subcutaneously in the upper arm region using a sterile needle and syringe for optimal immunization. It is important that the vaccine is used on the day it is reconstituted, ensuring maximum efficiency. The provided diluent must be used exclusively for reconstitution.
Immunization schedules are subject to vary in accordance to regional risk factors. Immunization can commence from as early as 9 months in high-risk areas, while in lower-risk areas, initiation can be postponed to 12-15 months. Adhering to the recommendation of two doses is crucial for complete protection. The MMR vaccine can be safely administered simultaneously with other vaccines.
Storage and Transport
The vaccine must be stored either in a refrigerator maintaining a temperature range between 2u00b0C and 8u00b0C or frozen at -20u00b0C. Freezing the vaccine and exposing it to sunlight should be scrupulously avoided. The diluent can be stored at room temperature or refrigerated.
